HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding HTG Molecular Diagnostics, Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 12 | 0 | −12 |
| Shares | 24.9K | 0 | −24.9K (−100.0%) |
| Value | $67.3K | $0 | −$67.3K (−100.0%) |
New holders (0)
Institutions that held HTG Molecular Diagnostics, Inc at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (12)
Institutions that held HTG Molecular Diagnostics, Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Vanguard Group Inc | 14,692 | $39.7K |
| UBS Group AG | 5,198 | $14.0K |
| Tower Research Capital LLC (TRC) | 1,481 | $4.00K |
| BlackRock Inc. | 1,289 | $3.48K |
| Morgan Stanley | 884 | $2.39K |
| HighMark Wealth Management LLC | 580 | $1.57K |
| Nordwand Advisors, LLC | 500 | $1.35K |
| Allworth Financial LP | 279 | $754 |
| Wells Fargo & Company | 13 | $35 |
| TCI Wealth Advisors, Inc. | 2 | $6 |
| JPMorgan Chase & Co | 10 | $0 |
| Royal Bank of Canada | 10 | $0 |